St. Louis, Missouri
April 16, 2002
Monsanto Company announced
today it is supporting a global effort to increase production
and quality of cassava by granting the
Donald Danforth Plant
Science Center
a royalty-free license to enabling technologies
commonly used in agricultural biotechnology.
"Monsanto is committed to advancing global agricultural research
and to using our technologies to benefit both science and
people," said Hendrik Verfaillie, Chief Executive Officer of
Monsanto Company.
"By providing this license we hope to accelerate valuable
research taking place in public and non-profit research
institutions to benefit the developing world."
Monsanto's technologies will support efforts already underway at
the Danforth Center to conduct research and further develop a
comprehensive global research plan to tackle the most
significant challenges facing cassava farmers, including control
of disease, post-harvest deterioration, and enhancing the
nutritional content of the crop.
"Part of the Danforth Center's mission is to facilitate the
development and transfer of technologies for developing
countries and we are pleased that we have received this license
from Monsanto toward that purpose," said Roger N. Beachy, Ph.D.,
President of the Danforth Center.
"By granting this license, Monsanto has enabled researchers at
the Danforth Center, and our collaborators around the world, to
continue our important work while now freely using Monsanto
technology to even further advance agricultural research on
cassava, a crop that hundreds of millions of people will
continue to rely upon for food security and economic development
in coming decades," he said.
Cassava, a tropical crop grown for its starchy, tuberous roots,
contributes to food security and rural income in many developing
countries and feeds nearly 600 million people daily. A recent
report by the United Nations singled out cassava as a priority
for additional research in developing countries.
The United Nations' Human Development Report 2001 also
encouraged greater public investment in research and development
to ensure that biotechnology is used to meet the agricultural
needs of the world's poor.
"By sharing our technology and other scientific knowledge,
Monsanto hopes to encourage other companies and technology
developers to do the same," said Robb Fraley, Chief Technology
Officer of Monsanto.
"Working together in public and private sector partnerships
promotes a wide variety of discoveries to enhance food security
and nutrition throughout the developing world. We look forward
to continuing our support of the cassava research program as it
develops," said Fraley.
Monsanto also is supporting the Danforth Center's efforts to
develop virus-resistant cassava through a multi-year grant from
the company's philanthropic organization, the Monsanto Fund.
Monsanto's contributions to the Danforth Center are in keeping
with the New Monsanto Pledge and its commitment to sharing
knowledge and technology with public institutions to benefit
people and the environment, particularly in the developing
world.
In August 2000, Monsanto granted similar royalty-free licenses
to the inventors of 'golden rice,' which is being developed to
combat vitamin A deficiency in developing countries. Other
sharing projects include providing access to a working draft of
the rice genome and participating in work to develop
virus-resistant sweet potatoes in Africa and papayas in South
East Asia.
The Donald Danforth Plant Science Center is a St. Louis-based
not-for-profit, basic research institution devoted to the
creation of new knowledge that will lead to the sustainable
production of nutritious and abundant food for the peoples of
the world. For more information on the Danforth Center, see:
www.danforthcenter.org .
Monsanto Company is a leading provider of agricultural solutions
to growers worldwide. Monsanto's employees provide top-quality,
cost-effective and integrated approaches to help farmers improve
their productivity and produce better quality foods.
|